Advertisement
Organisation › Details
Touchlight (Group)
Touchlight is a privately-owned biotechnology company based in London, U.K., focussed on the discovery and development of DNA-based genetic medicines, including DNA vaccines and gene therapies. Touchlight has developed a novel, synthetic DNA vector known as “doggybone” or dbDNA™. dbDNA™ is a minimal, linear, covalently closed structure, that eliminates bacterial sequences. Touchlight’s revolutionary enzymatic production platform enables unprecedented speed, scale, and the ability to target genes with a size and complexity that is impossible with current technologies. Touchlight is applying dbDNA across advanced therapeutic modalities, both in-house and with partners. The company also provides contract manufacturing capabilities to produce dbDNA as a critical starting material for advanced therapy production through its manufacturing arm, Touchlight DNA Services. *
Start | 2008-01-01 established | |
Industry | BIOTECH | |
Industry 2 | genomic technology | |
Person | Ohlson, Jonny (Touchlight Genetics 201606 CEO) | |
Person 2 | Milsom, Sarah (Touchlight Genetics 201606 Business Development Manager) | |
Region | Hampton, Middlesex | |
Country | United Kingdom (GB) | |
Street | Lower Sunbury Road Morelands & Riverdale Buildings | |
City | TW12 2ER Hampton, Middlesex | |
Tel | +44-20-8481-9200 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Touchlight Genetics Ltd.. (10/15/20). "Press Release: Touchlight Appoints Karen Fallen as CEO of Touchlight DNA Services". Hampton. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Touchlight (Group)
- [1] Touchlight Genetics Ltd.. (11/29/22). "Press Release: Touchlight Receives Grant to Advance Rapid, Scalable and Thermostable doggybone DNA Vaccine Platform". Hampton....
- [2] Touchlight Genetics Ltd.. (11/15/22). "Press Release: Touchlight Signs License Agreement with Voyager for Use of Touchlight’s DNA Technology in Voyager’s Capsid Discovery Platform". Hampton....
- [3] Touchlight Genetics Ltd.. (7/6/22). "Press Release: Touchlight Signs Patent License Agreement with Pfizer for the Use of dbDNA for the Manufacture of mRNA-based Vaccines, Therapeutics and Gene Therapies". Hampton....
- [4] LenioBio GmbH. (3/7/22). "Press Release: LenioBio Closes Its Series-A Extension Round and Strengthens Its Board of Directors". Düsseldorf....
- [5] Touchlight Genetics Ltd.. (9/15/21). "Press Release: Touchlight Extends Funding Round to US$125M as Demand for Its dbDNA Grows Rapidly"....
- [6] Touchlight Genetics Ltd.. (3/11/21). "Press Release: Touchlight Raises £42 Million ($58 Million) to Meet Unprecedented Global DNA Demand". Hampton....
- [7] Touchlight Genetics Ltd.. (10/15/20). "Press Release: Touchlight Appoints Karen Fallen as CEO of Touchlight DNA Services". Hampton....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top